Effects of dipeptidyl peptidase‐4 inhibitor linagliptin versus sulphonylurea glimepiride on systemic haemodynamics in overweight patients with type 2 diabetes: A secondary analysis of an 8‐week, randomized, controlled, double‐blind trial

AIM: To determine the glucose‐independent effect of the dipeptidyl peptidase‐4 (DPP‐4) inhibitor linagliptin versus the sulphonylurea glimepiride on systemic haemodynamics in the fasting and postprandial state in patients with type 2 diabetes (T2D). MATERIALS AND METHODS: In this prespecified second...

Descripción completa

Detalles Bibliográficos
Autores principales: Kraaijenhof, Jordan, Muskiet, Marcel H. A., Tonneijck, Lennart, Ouwens, D. Margriet, Kramer, Mark H. H., van Raalte, Daniël H., Smits, Mark M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7540521/
https://www.ncbi.nlm.nih.gov/pubmed/32476255
http://dx.doi.org/10.1111/dom.14107

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7540521/
https://www.ncbi.nlm.nih.gov/pubmed/32476255
http://dx.doi.org/10.1111/dom.14107

Ejemplares similares